Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants

ClinicalTrials.gov ID: NCT03765073

Public ClinicalTrials.gov record NCT03765073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1/2, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY NONPREGNANT WOMEN AND PREGNANT WOMEN 18 TO 40 YEARS OF AGE AND THEIR INFANTS

Study identification

NCT ID
NCT03765073
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
1,208 participants

Conditions and interventions

Interventions

  • Multivalent Group B streptococcus vaccine Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
0 Years to 40 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2019
Primary completion
Mar 3, 2024
Completion
Mar 3, 2024
Last update posted
Aug 4, 2025

2019 – 2024

United States locations

U.S. sites
26
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Velocity Clinical Research Mobile Alabama 36608
Velocity Clinical Research, Phoenix Phoenix Arizona 85006
Chemidox Clinical Trials Inc. Lancaster California 93534
Chemidox Clinical Trials Inc Lancaster California 93534
Emerson Clinical Research Institute Washington D.C. District of Columbia 20009
Clinical Research Prime Idaho Falls Idaho 83404
Clinical Research Prime Rexburg Rexburg Idaho 83440
Lakeview Regional Medical Center Covington Louisiana 70433
MedPharmics Covington Louisiana 70433
St. Tammany Parish Hospital Covington Louisiana 70433
North Oaks Medical Center Hammond Louisiana 70403
North Oaks Obstetrics & Gynecology Hammond Louisiana 70403
Velocity Clinical Research Slidell Louisiana 70458
Boeson Research Missoula Montana 59804
Community Hospital Missoula Montana 59804
The Birth Center Missoula Montana 59804
Meridian Clinical Research Hastings Nebraska 68901
Frontier Pediatric Care (Follow-Up Visits for Infant Participants) Lincoln Nebraska 68506
Bryan Women's Care Physicians (Maternal Visits & Obstetric Exams) Lincoln Nebraska 68510
Be Well Clinical Studies Lincoln Nebraska 68516
Lowcountry Women's Specialists Summerville South Carolina 29485
Summerville Medical Center Summerville South Carolina 29485
Coastal Pediatric Research Summerville South Carolina 29486
Sentara Leigh Hospital Norfolk Virginia 23502
The Group for Women Norfolk Virginia 23502
Tidewater Physicians for Women Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03765073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03765073 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →